ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1895

Safety Competences Knowledge and Behavioural Skills of Patients Treated by Biologics in Rheumatology

Anne-Christine Rat1, Bruno Fautrel2, Elisabeth Flipon3, Laure Gossec4, Benoit-Damien Caritey5, Laurent Marguerie6, Henri Nataf7, Beatrice Pallot Prades8, Rose Marie Poilvert9, Valerie Royant10, Fathia Sadji11, Christelle Sordet12, Corinne Thevenot13 and Catherine Beauvais14, 1CHU Nancy, Clinical Epidemiology and Evaluation, Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Nancy, France, 2Rheumatology / GRC08-EEMOIS, APHP-Pitie Salpetriere Hospital / UPMC, Paris, France, 3Cochin hospital, Paris, France, 4Rheumatology B Department, Paris-Descartes University, Cochin Hospital, Paris, France, 5Epidemiology, Université de lorraine, Nancy, France, 6Rheumatology department, Institut Calot, Berck, France, 7Mantes-la-Jolie, Mantes-la-Jolie, France, 8Rheumatology department, Saint Etienne university hospital, Saint Etienne, France, 9Rheumatology department, Saint Antoine Hospital, Paris, France, 10Chartres, Chartres, 11Rheumatology department, Victor Jousselin Hospital, Dreux, France, 12Rheumatology, Strasbourg University Hospital, Strasbourg, France, 13Department of Internal Medicine, Laon hospital, Laon, France, 14Rhumatologie, Saint Antoine, Paris, France

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: drug therapy, Education, inflammatory arthritis and skill development, patient

  • Tweet
  • Email
  • Print
Session Information

Title: Medical Education

Session Type: Abstract Submissions (ACR)

Background/Purpose: Biologics are known to entail specific risks; therefore teaching patients safety skills, appropriate behaviours in situations of risks and what decisions to take in these situations is necessary. The level of knowledge of safety competences are not well known in patients treated by biologics.The objective of the study was to describe the safety competences of patients treated by biologics for inflammatory arthritis and to determine the factors associated with a lower level of competences.

Methods: Data were obtained from a national cross-sectional survey. To be as representative as possible of the patients treated by biologics, rheumatologists were randomly sampled from the national directory. They were invited to include 3 to 5 consecutive patients treated by biologics whatever their inflammatory arthritis diagnosis.All patients completed a 55-item questionnaire (BioSecure*) assessing patients’ self-care safety skills and sociodemographic characteristics, type of information received, quality of life and coping style data. Rheumatologists completed personal and practice data.The questionnaire measuring knowledge and skills regarding biologics was developed by health professional and patients using 3 steps: elaboration of an exhaustive list of competences, selection via a Delphi technique then elaboration of a questionnaire for the 26 competences selected. The questionnaire includes a series of multiple-choice questions on knowledge and on clinical situations grouped in dimensions.

Results: Of the 671 patients included, 67% were women, 62% had RA and 38% spondylarthritis, 63% were treated by subcutaneous antiTNF. The mean age was 53±13 years old. Patients received information during a medical consultation (90%), a consultation with a nurse (30%), with a written booklet (59%) and during a therapeutic education program (11%). The median total score (percentage of right items) was 73 (interquartile 60-82). Knowledge items had not higher percentages of correct answers than behavioural skills items. Scores and number (%) of patients with a number of correct answers lower than 50% are described in the table. In multivariate analysis, several patients’ factors were associated with a lower level of competences: living alone, a lower education level, living in a big city, not to be employed and having not received written information or therapeutic education. Rheumatologists treating more than 80 patients with biologists had an increased risk of having their patients in the moderate skills group compared to the high skills group.

 

 

N° items

 

 

 

Patients with a  n° of wright items < 50%

 

 

 

Median

Q1

Q3

N

%

Biologics management

 

11

100.0

90.9

100.0

12

(1.8)

 

General knowledge

4

100.0

75

100.0

24

(3.6)

 

Communication

4

100.0

100

100

17

(2.5)

When to consult

 

15

73.3

53.3

86.7

145

(21.4)

 

Fever

11

81.8

54.5

90.9

127

(18.8)

 

Infectious symptoms

4

75.0

25

100

188

(27.8)

Specific situations

 

19

73.7

52.6

84.2

128

(18.9)

 

Vaccination. Injuries

8

62.5

50

87.5

167

(24.7)

 

Dental care

2

100.0

50

100

79

(11.7)

 

Surgery

7

85.7

57.1

100

86

(12.7)

 

Planning child conception

2

50.0

0

100

336

(49.6)

Sub-cutaneous injection

 

3

66.7

66.7

66.7

245

(36.2)

Conclusion: Safety competences can be improved, especially competences needed to deal with infectious symptoms, vaccinations, planned surgery and planning child conception. These results provide also elements to help identifying patients who need therapeutic education or to adapt the messages given.

*L Gossec. Ann Rheum Dis 2010;69(Suppl3):476


Disclosure:

A. C. Rat,
None;

B. Fautrel,
None;

E. Flipon,
None;

L. Gossec,
None;

B. D. Caritey,
None;

L. Marguerie,
None;

H. Nataf,
None;

B. Pallot Prades,
None;

R. M. Poilvert,
None;

V. Royant,
None;

F. Sadji,
None;

C. Sordet,
None;

C. Thevenot,
None;

C. Beauvais,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/safety-competences-knowledge-and-behavioural-skills-of-patients-treated-by-biologics-in-rheumatology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology